<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03221491</url>
  </required_header>
  <id_info>
    <org_study_id>Different Background Infusion</org_study_id>
    <nct_id>NCT03221491</nct_id>
  </id_info>
  <brief_title>Comparison of Patient-Controlled Analgesia With Different Background Infusion</brief_title>
  <official_title>Comparison of Intravenous Patient-Controlled Analgesia With Different Background Infusion After Colorectal Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Weifeng Tu</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Guangzhou General Hospital of Guangzhou Military Command</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, the investigators investigated the efficacy, usefulness and analgesic
      consumption of three different patient-controlled analgesia(PCA) programmes:bolus dose alone
      without background infusion, bolus dose with low background infusion and bolus dose with high
      background infusion to evaluate postoperative analgesia for patients after laparoscopic
      colorectal surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There have been many studies using patient-controlled analgesia (PCA) and opioids for
      postoperative analgesia.Patient-controlled analgesia with opioids is now widely used after
      surgery for the treatment of acute postoperative pain. This technique provides effective pain
      treatment, adjusts the dose according to personal need and keeps plasma analgesic levels at a
      constant level,but the incidence of opioid-induced side-effects still be reported
      frequently.A proper PCA programme may increase efficiency of analgesic and decrease incidence
      of analgesic-induced side-effects.

      In this study, 90 patients who is undergoing elective laparoscopic colorectal surgery will be
      randomly allocated into three groups (no background infusion group(Group B0),low background
      infusion group(Group B1) and high background infusion group(Group B2)). Patients in all
      groups will be given a patient-controlled analgesia (PCA) pump in post anesthetic recovery
      unit (PACU) after surgery.The PCA programme of Group B0 is dezocine 0.6mg/kg, flubiprofen
      3mg/kg, diluted into 120ml and administer at a background infusion of 0ml/h, and a bolus of
      4ml, with a lock-out of 15min. The PCA protocol of Group B1 is dezocine 0.6mg/kg,flubiprofen
      3mg/k diluted into 120ml and administer at a background infusion of 1ml/h, and a bolus of
      2ml, with a lock-out of 15min.The PCA protocol of Group B2 is dezocine 0.6mg/kg,flubiprofen
      3mg/k diluted into 120ml and administer at a background infusion of 2ml/h, and a bolus of
      2ml, with a lock-out of 15min.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 1, 2016</start_date>
  <completion_date type="Actual">June 30, 2017</completion_date>
  <primary_completion_date type="Actual">June 30, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Dezocine consumption by patient-controlled analgesia</measure>
    <time_frame>At 24 hours after surgery</time_frame>
    <description>The total consumption of dezocine during 24 hours after surgery are recorded.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The incidence rates of postoperative nausea and vomiting (PONV)</measure>
    <time_frame>At 24 hours and 48 hours after surgery</time_frame>
    <description>Measure whether nausea and vomiting exist and the level of severity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in ramsay sedation score</measure>
    <time_frame>At 0, 2, 4, 8, 24, 48 and 72 hours after surgery</time_frame>
    <description>Measure sedation level by using ramsay sedation score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in pain score</measure>
    <time_frame>At 0, 2, 4, 8, 24, 48 and 72 hours after surgery</time_frame>
    <description>Pain scores at rest and movement are evaluated with a numeric rating scale (NRS)</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Patient-Controlled Analgesia</condition>
  <arm_group>
    <arm_group_label>No Background Infusion Group(Group B0)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in Group B0 receive analgesic regimens using Patient-Controlled Analgesia(PCA) with background infusion 0ml/h.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low Background Infusion Group(Group B1)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in Group B1 receive analgesic regimens using Patient-Controlled Analgesia(PCA) with background infusion 1ml/h.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High Background Infusion Group(Group B2)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in Group B2 receive analgesic regimens using Patient-Controlled Analgesia(PCA) with background infusion 2ml/h.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Patient-Controlled Analgesia(PCA)</intervention_name>
    <description>Patients receive analgesic regimens using Patient-Controlled Analgesia(PCA) with different background infusion.</description>
    <arm_group_label>No Background Infusion Group(Group B0)</arm_group_label>
    <arm_group_label>Low Background Infusion Group(Group B1)</arm_group_label>
    <arm_group_label>High Background Infusion Group(Group B2)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. American Society of Anesthesiologists(ASA) Ⅰ-Ⅱ patient undergoing laparoscopic
             colorectal surgery

          2. Written informed consent from the patient or the relatives of the participating
             patient.

          3. BMI:18～30kg/m2

        Exclusion Criteria:

          1. Mental illness or cannot communicate.;

          2. A second operation during the study;

          3. Lung infection or sleep apnea syndrome;

          4. Renal failure;

          5. Alcohol or drug abuse;

          6. Already taking gabapentin, pregabalin, benzodiazepin or antidepression drug;

          7. Long-term use of analgesics,sedatives or non steroidal anti-inflammatory drugs history
             .
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Guangzhou General Hospital of Guangzhou Military Command</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510010</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Doyle E, Harper I, Morton NS. Patient-controlled analgesia with low dose background infusions after lower abdominal surgery in children. Br J Anaesth. 1993 Dec;71(6):818-22.</citation>
    <PMID>8280546</PMID>
  </reference>
  <reference>
    <citation>Yildiz K, Tercan E, Dogru K, Ozkan U, Boyaci A. Comparison of patient-controlled analgesia with and without a background infusion after appendicectomy in children. Paediatr Anaesth. 2003 Jun;13(5):427-31.</citation>
    <PMID>12791117</PMID>
  </reference>
  <reference>
    <citation>White I, Ghinea R, Avital S, Chazan S, Dolkart O, Weinbroum AA. Morphine at &quot;sub-analgesic&quot; background infusion rate plus low-dose PCA bolus control pain better and is as safe as twice a bolus-only PCA regimen: a randomized, double blind study. Pharmacol Res. 2012 Aug;66(2):185-91. doi: 10.1016/j.phrs.2012.03.016. Epub 2012 Apr 6.</citation>
    <PMID>22504462</PMID>
  </reference>
  <reference>
    <citation>Hayes J, Dowling JJ, Peliowski A, Crawford MW, Johnston B. Patient-Controlled Analgesia Plus Background Opioid Infusion for Postoperative Pain in Children: A Systematic Review and Meta-Analysis of Randomized Trials. Anesth Analg. 2016 Oct;123(4):991-1003. doi: 10.1213/ANE.0000000000001244. Review.</citation>
    <PMID>27065359</PMID>
  </reference>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 16, 2017</study_first_submitted>
  <study_first_submitted_qc>July 16, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 18, 2017</study_first_posted>
  <last_update_submitted>July 18, 2017</last_update_submitted>
  <last_update_submitted_qc>July 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Guangzhou General Hospital of Guangzhou Military Command</investigator_affiliation>
    <investigator_full_name>Weifeng Tu</investigator_full_name>
    <investigator_title>Chief physician</investigator_title>
  </responsible_party>
  <keyword>Analgesia</keyword>
  <keyword>Colorectal Surgery</keyword>
  <keyword>Background Infusion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Agnosia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Analgesics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

